Searched for
ATOPIC DERMATITIS TREATMENT
J&J acquires experimental skin disorder drug for $1.25 billionNUMAB THERAPEUTICS-JOHNSON&JOHNSON/M&A (UPDATE 2, PIX)UPDATE 2-J&J acquires experimental skin disorder drug for $1.25 billion28 May, 2024, 07.36 PM IST- Sanofi looks for accelerated growth in India; plans fast-tracking of product pipelineSanofi, a leading French pharmaceutical company, aims to expand its presence in the Indian market by introducing new drugs, enhancing local...07 Apr, 2024, 11.22 AM IST
- Glenmark partners with Pfizer to launch abrocitinib in India to treat atopic dermatitisGlenmark and Pfizer will co-market abrocitinib in India under the brand names JABRYUS and CIBINQO. Developed by Pfizer, abrocitinib has rec...31 Jan, 2024, 06.07 PM IST
- Believe it or not, your food & pollen allergies may be protecting you from catching CovidNew research said that people with atopic diseases have 25% lower odds of contracting Covid.25 Aug, 2022, 06.13 PM IST
- Jayalalithaa death: AIIMS panel gives clean chit to Apollo Hospital, says "correct" medical procedures followedAIIMS panel of doctors has asserted that the treatment provided to late Tamil Nadu Chief Minister Jayalalithaa was as per "correct medical ...21 Aug, 2022, 01.28 PM IST
- Glenmark looks to license out second drug assetGlenmark chairman and managing director Glenn Saldanha said one of the corporate objectives of the Mumbai-headquartered company is to do at...16 Dec, 2021, 06.33 AM IST
- Stocks in the news: Vodafone Idea, RIL, Cadila Healthcare, PNB Housing and VoltasGoogle is said to be exploring taking a minority stake in British telecom group Vodafone’s struggling India business.29 May, 2020, 12.31 PM IST
- Trending stocks: Sun Pharma shares up nearly 1%A total of 134,539 shares changed hands on the counter till 11:30AM (IST).29 May, 2020, 11.35 AM IST
- N Rajaram on how Sanofi plans to be in pink of health in India“PM’s Ayushman Bharat policy will give an opportunity for various players in healthcare sector to grow.”27 Sep, 2018, 05.03 PM IST
- Sanofi and Regeneron's eczema drug gets FDA approvalThe FDA approved Dupixent (dupilumab), is the first targeted biologic therapy for adults with moderate-to-severe atopic dermatitis.29 Mar, 2017, 05.09 PM IST
- Common bacteria can actually protect you against skin diseaseOxidative stress is considered to be a contributing factor in several skin diseases.12 Nov, 2016, 06.13 PM IST
- Sanofi bets on dengue vaccine, 5 other drugs to bolster India playFrench co plans to bring raft of innovative products, including preventive dengue vaccine; move may improve company’s prospects over its ri...31 Oct, 2015, 03.56 AM IST
- Arthritis drug may treat eczemaStandard treatments, such as steroid creams and oral medicines, commonly fail to relieve symptoms in patients with moderate to severe eczem...21 Jul, 2015, 05.32 PM IST
- Glenmark launches generic Hydrocortisone Butyrate cream in USThe company's current portfolio consists of 90 products authorised for distribution in the US market and 56 ANDA's pending approval before ...09 Dec, 2013, 01.16 PM IST
- Glenmark Generics Inc files law suit to enforce licence pactThe agreement is with Triax Pharmaceuticals, Astellas Pharma Europe BV and Astellas Pharma International BV.10 Oct, 2013, 04.38 PM IST
- Glenmark gets USFDA nod for skin infections creamGlenmark Pharmaceuticals received approval from USFDA for its generic Hydrocortisone Butyrate Cream used for treating skin infections.30 Sep, 2013, 01.39 PM IST
- Lupin signs pact with Onset to sell skin disease lotion in USLupin signed an agreement with Onset Dermatologics under which it will market the latter's skin disease treatment medicine in US market.23 Sep, 2013, 05.23 PM IST
Load More
